Key result
Pharmacological inhibition of cathepsin A protease activity at reperfusion prevented extracellular matrix remodeling in the atrium and remote ventricle in a rat model of ischemia/reperfusion.
Why the study?
After myocardial infarction, remote ventricular remodeling and atrial cardiomyopathy progress despite successful revascularization.
Does pharmacological inhibition of cathepsin A prevent remote ventricular remodeling and atrial cardiomyopathy in a rat model of ventricular ischemia/reperfusion?
Does pharmacological inhibition of cathepsin A prevent remote ventricular remodeling and atrial cardiomyopathy in a rat model of ventricular ischemia/reperfusion?
Inhibition of cathepsin A at reperfusion prevents remote ventricular remodeling and atrial cardiomyopathy in a rat model of ischemia/reperfusion, suggesting a potential upstream therapy for atrial fibrillation post-MI.
Cathepsin A inhibition at reperfusion attenuates remodeling in rats; hypothesis-generating for post-MI AF prevention in humans.
After myocardial infarction, remote ventricular remodeling and atrial cardiomyopathy progress despite successful revascularization. In a rat model of ventricular ischemia/reperfusion, pharmacological inhibition of the protease activity of cathepsin A initiated at the time point of reperfusion prevented extracellular matrix remodeling in the atrium and the ventricle remote from the infarcted area. This scenario was associated with preservation of more viable ventricular myocardium and the prevention of an arrhythmogenic and functional substrate for atrial fibrillation. Remote ventricular extracellular matrix remodeling and atrial cardiomyopathy may represent a promising target for pharmacological atrial fibrillation upstream therapy following myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Hohl et al. (2019) studied Ventricular ischemia/reperfusion. Pharmacological inhibition of the protease activity of cathepsin A was evaluated on Extracellular matrix remodeling in the atrium and the ventricle remote from the infarcted area. Pharmacological inhibition of cathepsin A protease activity at reperfusion prevented extracellular matrix remodeling in the atrium and remote ventricle in a rat model of ischemia/reperfusion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: